Study guide

2.4 Complications of Acute Myocardial Infarction

AACN Cardiac Medicine Certification CMC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview and the CMC Test Plan

1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them

2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease

2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy

3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease

3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup

4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions

4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation

5 Chapter 5: Vascular Conditions and Vascular Interventions

5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications

6 Chapter 6: Shock States and Mechanical Circulatory Support

6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD

7 Chapter 7: Cardiac Procedures and Structural Heart Interventions

7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications

8 Chapter 8: Cardiovascular Pharmacology

8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure

9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary

9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients

10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral

10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients

11 Chapter 11: Monitoring and Diagnostics

11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography

12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions

12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease

2.4 Complications of Acute Myocardial Infarction

Key Takeaways Explain This Topic AI

Mechanical complications of MI—including acute mitral regurgitation from papillary muscle rupture, ventricular septal defect (VSD), and free wall rupture—typically manifest 2 to 7 days post-MI and present with sudden hemodynamic collapse.

A Pulmonary Artery Catheter (PAC) differentiates mechanical complications: papillary muscle rupture causes giant v-waves on PAWP tracings, whereas VSD produces a significant oxygen saturation step-up (≥ 5% at the ventricular level) from the Right Atrium to the Right Ventricle.

Right Ventricular Infarction presents with the classic triad of hypotension, clear lung fields, and elevated JVD; treatment centers on IV fluid volume loading while strictly avoiding preload reducers like nitrates, morphine, and diuretics.

Early peri-infarction pericarditis occurs within 1-3 days post-MI and is managed with high-dose aspirin, avoiding standard NSAIDs and corticosteroids which impair myocardial scar healing and increase rupture risk.

Last updated: August 2026

Mechanical Complications of Acute Myocardial Infarction

Mechanical complications represent catastrophic structural ruptures occurring primarily between days 2 and 7 post-MI (the period of peak macrophage infiltration and tissue softening during necrosis clearance). Although less common in the primary PCI era, they carry acute mortality rates exceeding 50%.

1. Acute Mitral Regurgitation Secondary to Papillary Muscle Rupture

Pathophysiology: Rupture of a necrotic papillary muscle or its chordae tendineae causes flail mitral valve leaflets and massive systolic regurgitation into the left atrium.

Vascular Vulnerability: Most commonly complicates inferior or posterolateral MIs . The posteromedial papillary muscle has a single blood supply from the posterolateral branch of the RCA or LCx, making it 6 to 10 times more prone to rupture than the anterolateral papillary muscle (which receives dual blood supply from both LAD and LCx).

Clinical Presentation: Sudden clinical deterioration with flash pulmonary edema, severe dyspnea, cardiogenic shock, and a new harsh, high-pitched holosystolic murmur heard best at the apex radiating to the axilla.

Pulmonary Artery Catheter (PAC) Finding: Demonstrates large, prominent v-waves on the pulmonary artery wedge pressure (PAWP) tracing, reflecting massive blood regurgitation into the left atrium during ventricular systole.

Management: Urgent echocardiography, intra-aortic balloon pump (IABP) or Impella placement for left ventricular unloading, IV vasodilators (nitroprusside) if SBP permits, and immediate emergency surgical valve repair/replacement.

2. Ventricular Septal Defect (VSD / Septal Rupture)

Pathophysiology: Coagulative necrosis of the interventricular septum creates a transmural tear connecting the high-pressure left ventricle to the low-pressure right ventricle.

Associated MI Territory: Occurs in both anterior MIs (apical septal rupture via LAD) and inferior MIs (basal septal rupture via RCA).

Clinical Presentation: Sudden biventricular failure, severe hypotension, cardiogenic shock, and a new, loud, harsh, holosystolic murmur heard best at the left lower sternal border (LLSB) , frequently accompanied by a palpable thrill .

PAC Finding: Demonstrates an oxygen saturation step-up (≥ 5% at the ventricular level, the classic Antman criterion; some sources use a more conservative ≥ 10%) between blood drawn from the Right Atrium (RA) and blood drawn from the Right Ventricle (RV) or Pulmonary Artery (PA), caused by oxygenated left ventricular blood shunting rightward across the defect.

Management: Emergency surgical or percutaneous device closure; hemodynamic stabilization with IABP and inotropes.

3. Left Ventricular Free Wall Rupture (FWR)

Pathophysiology: Full-thickness tear of the necrotic ventricular free wall into the pericardial sac, resulting in rapid hemopericardium.

Clinical Presentation: Typically presents as sudden electromechanical dissociation (PEA) , acute cardiac tamponade (Beck's Triad: hypotension, muffled heart sounds, JVD), pulsus paradoxus, and rapid cardiovascular collapse.

Management: Immediate emergency pericardiocentesis to relieve tamponade, accompanied by emergency open cardiac surgery.

Loading diagram... Post-MI Mechanical Complications Diagnostic Matrix

Electrical Complications: Arrhythmias & Conduction Blocks

Ischemia disrupts cardiac cell membrane resting potentials, slows conduction velocity, and promotes re-entry pathways.

Ventricular Arrhythmias

Early Ventricular Fibrillation (VF) / Ventricular Tachycardia (VT): Occurs within the first 24 to 48 hours post-MI due to ischemic cellular instability ("primary VF"). Managed with immediate defibrillation/cardioversion and IV Amiodarone or Lidocaine. Primary VF does not adversely alter long-term prognosis if successfully resuscitated.

Late VF / VT (>48 Hours Post-MI): Indicates established myocardial scar tissue and carries a grave long-term prognosis, requiring electrophysiology consultation and evaluation for an Implantable Cardioverter-Defibrillator (ICD).

Bradyarrhythmias and Conduction Blocks by MI Location

Conduction disturbances differ radically based on coronary anatomy:

Inferior MI (RCA Occlusion):

Mechanism: The RCA supplies the AV node via the AV nodal artery in 90% of individuals. Ischemia induces hypervagotonia and AV nodal ischemia.

Conduction Block Type: Sinus Bradycardia and Mobitz Type I (Wenckebach) 2nd-Degree AV Block .

Characteristics: Nodal (narrow QRS), hemodynamically stable or transient, and highly responsive to Atropine (1 mg IV, repeated every 3–5 minutes to a maximum of 3 mg). Rarely requires permanent pacing.

Anterior MI (LAD Occlusion):

Mechanism: The septal perforators of the LAD supply the bundle of His and bundle branches below the AV node.

Conduction Block Type: Mobitz Type II 2nd-Degree AV Block or Complete (3rd-Degree) Heart Block .

Characteristics: Infranodal block featuring a wide QRS escape rhythm , marked hemodynamic instability, and high risk of sudden ventricular asystole. Destruction of the conduction system is extensive.

Nursing Management: Atropine is ineffective and contraindicated for infranodal blocks because it accelerates the sinus node without improving infranodal conduction, worsening block. Immediate transcutaneous pacing (TCP) must be initiated, followed by transvenous pacemaker insertion.

  • Hemodynamic Complications: RV Infarction & Cardiogenic Shock
  • Right Ventricular Infarction Management

Right ventricular infarction accompanies inferior STEMI in 30-50% of cases. Because the right ventricle is thin-walled, acute ischemic necrosis impairs RV contractile force, reducing forward stroke volume into the pulmonary circulation.

Clinical Triad: Hypotension, clear lung fields on auscultation, and marked jugular venous distention (JVD).

PAC Hemodynamics: Elevated Right Atrial Pressure (RAP/CVP ≥ 10-15 mmHg) with normal or low Pulmonary Artery Wedge Pressure (PAWP <12 mmHg) and low Cardiac Index (CI <2.0 L/min/m²).

Treatment Principles:

Volume Loading: Administer IV isotonic saline boluses to raise RV preload, driving blood passively across the pulmonary bed into the left atrium.

Strict Contraindications: Preload-reducing drugs are strictly prohibited! Avoid Nitrates, Morphine, Diuretics, and ACE Inhibitors. Reducing preload in RV MI destroys forward cardiac output, precipitating profound cardiac arrest.

Inotropic Support: Administer Dobutamine if fluid administration fails to restore mean arterial pressure.

Cardiogenic Shock (CS)

Cardiogenic shock occurs when >40% of left ventricular mass undergoes acute necrosis, leading to severe end-organ hypoperfusion.

Hemodynamic Parameters: Systolic BP <90 mmHg, Cardiac Index <2.2 L/min/m², PAWP >15 mmHg, and Systemic Vascular Resistance (SVR >1500 dyn·s·cm⁻⁵).

Inotropic & Vasopressor Management: Norepinephrine is the first-line vasopressor for severe hypotension. Dobutamine or Milrinone provides inotropic support to augment contractility.

Mechanical Circulatory Support (MCS): Escalation to Intra-Aortic Balloon Pump (IABP), Impella (percutaneous microaxial flow pump), or VA-ECMO to reduce LV wall stress and restore systemic perfusion.

Pericardial Complications: Early Pericarditis vs. Dressler Syndrome

  • Feature Early Peri-Infarction Pericarditis Dressler Syndrome (Post-Cardiac Injury)
  • Timing Post-MI 1 to 3 days post-MI 2 to 6 weeks post-MI

Etiology Direct local inflammatory extension of transmural necrosis to epicardial pericardium Autoimmune reaction driven by anti-myocardial antibodies and immune complexes

Chest Pain Characteristics Sharp, pleuritic, radiating to trapezius ridge; worse supine and with inspiration, relieved sitting forward Pleuritic chest pain accompanied by low-grade fever, malaise, and arthralgias

Physical Exam Pericardial friction rub audible at left sternal border Pericardial friction rub, pericardial effusion, pleural effusion

ECG Presentation Diffuse, concave ST elevation and PR depression across multiple leads (except aVR) Diffuse ST elevation and PR depression

Pharmacological Treatment High-dose Aspirin (650 mg PO Q4-6h) plus Colchicine (ESC recommends colchicine for post-cardiac-injury syndromes, halving recurrence); acetaminophen as adjunctive analgesia Aspirin plus Colchicine ; NSAIDs (ibuprofen) can be used since scar tissue has matured

Contraindicated Agents NSAIDs (ibuprofen, indomethacin) & Corticosteroids are strictly contraindicated (impair scar healing, increase rupture risk) Corticosteroids reserved for severe refractory cases